Role of cholecystokinin in the regulation of liquid gastric emptying and gastric motility in humans: Studies with the CCK antagonist loxiglumide

Gut

Volumn 41, Issue 4, 1997, Pages 500-504

  Schwizer, W ^a   Borovicka, J ^b   Kunz, P ^c   Fraser, R ^b   Kreiss, C ^b   D'Amato, M ^d   Crelier, G ^c   Boesiger, P ^c   Fried, M ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^c UNIVERSITY OF ZURICH   (Switzerland)

^d Rotta Research Laboratorium   (Italy)

Author keywords

Antral contraction; Gastric emptying; Gastric motility; Loxiglumide; Magnetic resonance imaging

Indexed keywords

CHOLECYSTOKININ; CHOLECYSTOKININ RECEPTOR BLOCKING AGENT; LOXIGLUMIDE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HORMONAL REGULATION; HUMAN; MALE; NORMAL HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; STOMACH ANTRUM; STOMACH EMPTYING; STOMACH MOTILITY;

EID: 0030848573     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.41.4.500     Document Type: Article

References (37)

1. Horowitz M, Dent J. Disordered gastric emptying: mechanical basis, assessment and treatment. Baillieres Clin Gastroenterol 1991; 5: 371-407.
2. Liddle R, Morita E, Conrad C, Williams J. Regulation of gastric emptying in humans by cholecystokinin. J Clin Invest 1986; 77: 992-6.
3. Kleibeuker J, Beekhuis H, Jansen J, Piers D, Lamers C. Cholecystokinin is a physiological hormonal mediator of fat-induced inhibition of gastric emptying in man. Eur J Clin Invest 1988; 18: 173-7.
4. Yamagishi T, Debas H. Cholecystokinin inhibits gastric emptying by acting on both proximal stomach and pylorus. Am J Physiol 1978; 234: E375-8.
5. Kuwahara A, Ozawa K, Yanaihara N. Effects of cholecystokinin-octapeptide on gastric motility of anesthetized dogs. Am J Physiol 1986; 251: G678-81.
6. Fraser R, Fone D, Horowitz M, Dent J. Cholecystokinin octapeptide stimulates phasic and tonic pyloric motility in humans. Gut 1993; 34: 33-7.
7. Scheurer U, Varga L, Drack E, Burki H, Halter F. Measurement of cholecystokinin octapeptide-induced motility of rat antrum, pylorus, and duodenum in vitro. Am J Physiol 1983; 244: G261-5.
8. Allescher H, Daniel E, Fox J, Kostolanska F, Rovati L. Effect of the novel cholecystokinin receptor antagonist CR-1392 on cholecystokinin-induced antroduodenal and pyloric motility in vivo. J Pharmacol Exp Ther 1989; 251: 1134-41.
9. Makovec F, Chiste R, Bani M, Pacini A, Setnikar I, Rovati L. New glutaramic derivatives with potent competitive and specific cholecystokinin-antagonistic activity. Arzneimittelforschung 1985; 35: 1048-51.
10. Rovati L. Pentanoic acid derivatives. In: Adler G, Beglinger C, eds. Cholecystokinin antagonists in gastroenerology. Berlin, Heidelberg: Springer Verlag, 1991: 65-9.
11. Setnikar I, Bani M, Cereda R, Chiste R, Makovec F, Pacini M, Revel L. Pharmacological characterisation of a new potent and specific nonpolypeptide cholecystokinin antagonist. Arzneimittelforschung 1987; 37: 703-7.
12. Setnikar I, Bani M, Cereda R, Chiste R, Makovec F, Pacini M, Revel L. Anticholecystokinin activities of loxiglumide. Arzneimittelforsehung 1987; 37: 1168-71.
13. Meyer B, Berglinger C, Janssen J, Rovati L, Werth B, Hildebrand P, Zach D. Role of cholecystokinin in regulation of gastrointestinal motor functions. Lancet 1989; ii: 12-15.
14. Fried M, Erlacher U, Schwizer W, Lochner C, Koerfer J, Beglinger C, Jansen J. Role of cholecystokinin in the regulation of gastric emptying and pancreatic enzyme secretion in humans. Studies with the cholecystokinin-receptor antagonist loxiglumide. Gastroenterology 1991; 101: 503-11.
15. Anvari M, Malbert C, Horowitz M, Jamieson G. Loxiglumide abolishes the effects of intraduodenal oleic acid on gastric motility and emptying. Neurogastroenterol Motil 1994; 6: 181-7.
16. Corazziari E, Ricci R, Bilotti D, Bontempo I, De'Medici A, Pallotta N, Torsoli A. Oral administration of loxiglumide (CCK antagonist) inhibits postprandial gallbladder contraction without affecting gastric emptying. Dig Dis Sci 1990; 35: 50-4.
17. Schmidt W, Creutzfeldt W, Schleser A, Choudhury A, Nustede R, Hocker M, Nitsche R. Role of CCK in regulation of pancreaticobiliary functions and GI motility in humans: effects of loxiglumide. Am J Physiol 1991; 260: G197-206.
18. Kreiss C, Schwizer W, Borovicka J, Jausen J, Bouloux C, Pignot R, Bisehof-Delaloye A. Effect of SR 27897B, a new CCK-A receptor antagonist on gastric emptying of a solid-liquid meal in humans [abstract]. Gastroenterology 1995; 108: A6 32.
19. Schwizer W, Maccke H, Fried M. Measurement of gastric emptying by magnetic resonance imaging in humans. Gastroenterology 1092; 103: 369-76.
20. Schwizer W, Fraser R, Borovicka J, Asal K, Crelier G, Boesiger P, Fried M. Measurement of proximal and distal gastric motility with magnetic resonance imaging. Am J Physiol 1946; 271:G217-22.
21. Schwizer W, Fraser R, Borovicka J, Crelier G, Boesiger P, Fried M. Measurement of gastric emptying and gastric motility by magnetic resonance imaginig (MRI). Dig Dis Sci 1994; 39: 101S-3S.
22. Schwizer W, Fraser R, Maecke H, Siebold K, Funk R, Fried M. Gd-DOTA as a gastrointestinal contrast agent for gastric emptying measurements with MRI. Magn Reson Imaging 1994; 31: 388-93.
23. Ricci Maccarini M, Ghidini C, Stanghellini V, Morselli Labate AM, Franzoso L, Barbara G, Corinaldesi R. Loxiglumide prevents the effects of dietary fats on gastric motility in humans [abstract], Gastroenterology 1991; 100: A487.
24. Kelly K. Gastric emptying of liquids and solids: role of proximal and distal stomach. Am J Physiol 1980; 239: G71-7.
25. Malbert C, Ruckebusch Y. Passage of chyme and contractile patterns at the antro-duodenal junction on the dog. In: Van Nueten JM, Schuurkes JAJ, Akkermans LMA, eds. Gastropyloro-duodenal coordination. Peierstield: Wrightson Biomedical Publishing, 1990; 197-208.
26. Houghton L, Read N, Heddle R, Horowitx M, Collins P, Chatterton B, Dent J. Relationship of the motor activity of the antrum, pylorus, and duodenum to gastric emptying of a solid-liquid mixed meal. Gastroenterology 1988; 94: 1285-91.
27. Heddle R, Collins P, Dent J, Horowitz M, Read N, Chatterton B, Houghton I. Motor mechanisms associated with slowing of the gastric emptying of a solid meal by an intraduodenal lipid infusion. J Gastroenterol Hepatol 1989; 4: 437-47.
28. Tougas G, Anvari M, Dent J, Somers S, Richards D, Stevenson G. Relation of pyloric motility to pyloric opening and closure in healthy subjects. Gut 1992; 33: 466-71.
29. Fraser R, Shearer T, Fuller J, Horowitz M, Dent J. Intravenous erythromycin overcomes small intestinal feedback on antral, pyloric and duodenal motility. Gastroenterology 1992; 103: 114-9.
30. Fone D, Akkermans L, Dent J, Horowitz M, Van der Schee E. Evaluation of patterns of human antral and pyloric motility with an antral wall motion detector. Am J Physiol 1990; 258: G616-23.
31. Azpiroz F, Malagelada J. Intestinal control of gastric tone. Am J Physiol 1985; 249: G501-9.
32. Camilleri M, Brown M, Malagelada J-R. Relationship between impaired gastric emptying and abnormal gastrointestinal motility. Gastroenterology 1986; 91: 94-9.
33. Camilleri M, Malagelada J-R. Abnormal intestinal motility in diabetics with the gastroparesis syndrome, Eur J Clin Invest 1984; 14: 120-7.
34. Fraser R, Maddox A, Horowitz, M, Dent J. Organization of antral, pyloric and duodenal motility in patients with gastroparesis. J Gastrointest Motil 1993; 5: 167-75.
35. Fraser R, Horowitz M, Maddox A, Dent J. Postprandial motility and gastric emptying in gastroparesis the effect of cisapride. Gut 1994; 35: 172-8.
36. Mearin F, Camilleri M, Malagelada J-R. Pyloric dysfunction in diabetes with recurrent nausea and vomiting. Gastroen- terology 1986; 90: 1919-25.
37. Read N, Houghton L. Physiology of gastric emptying and pathophysiology of gastroparesis. Gastroenterol Clin North Am 1989; 18: 359-73.